Literature DB >> 12364897

[Daily sources of stress among HIV-positive women].

Leticia Gaspar Tunala1.   

Abstract

OBJECTIVE: To categorize and describe the daily sources of stress encountered by HIV-infected women.
METHODS: Using a semi-structured questionnaire, 150 interviews were conducted among HIV-infected women who attended the Reference and Treatment Center for Sexually Transmitted Diseases and Aids in the state of São Paulo, Brazil, between July and December 1997. The studied variables were: demographics, family structure, risk perception, sexuality, access to health system, treatment compliance, drug use, and significant and stressful events. Stressful events are further discussed here.
RESULTS: Only 14% of the stressful events are directly related to the treatment and illness itself. Sources of stress were categorized as follows: family relations (17%); partner relationship (12%); children (14%); illness (14%); non-family relationship (9%); financial (8%); professional (7%); discrimination issues (7%); others (4%); and no response (8%).
CONCLUSIONS: Stressful events are mainly related to affective/relationship sources, most often associated to the HIV stigma and mostly to women-related subjects. Health care professionals should provide integral care to HIV-infected women.

Entities:  

Mesh:

Year:  2002        PMID: 12364897

Source DB:  PubMed          Journal:  Rev Saude Publica        ISSN: 0034-8910            Impact factor:   2.106


  2 in total

1.  Brazilian mothers with HIV: experiences with diagnosis and treatment in a human rights based health care system.

Authors:  Jessica Scott Jerome; Marli Teresinha Gimeniz Galvao; Stacy Tessler Lindau
Journal:  AIDS Care       Date:  2011-12-07

2.  The impact of universal access to antiretroviral therapy on HIV stigma in Botswana.

Authors:  William R Wolfe; Sheri D Weiser; Karen Leiter; Wayne T Steward; Fiona Percy-de Korte; Nthabiseng Phaladze; Vincent Iacopino; Michele Heisler
Journal:  Am J Public Health       Date:  2008-08-13       Impact factor: 9.308

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.